Evidence map›Paper›PMID 38243137›Full record

ArticleEMBO reports2024

Glucose-derived glutamate drives neuronal terminal differentiation in vitro.

Laura D'Andrea, Matteo Audano, Silvia Pedretti, Silvia Pelucchi, Ramona Stringhi, Gabriele Imperato, Giulia De Cesare, Clara Cambria, Marine H Laporte, Nicola Zamboni and 4 more

Open access · diamondAbstract read
In one paragraph

Article in EMBO reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Laura D'Andrea *Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Via Giuseppe Balzaretti 9, 20133, Milan, Italy.ORCID 0000-0002-2042-9782
Matteo Audano *Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Via Giuseppe Balzaretti 9, 20133, Milan, Italy.
Silvia PedrettiDepartment of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Via Giuseppe Balzaretti 9, 20133, Milan, Italy.ORCID 0000-0001-6404-6321
Silvia PelucchiDepartment of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Via Giuseppe Balzaretti 9, 20133, Milan, Italy.
Ramona StringhiDepartment of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Via Giuseppe Balzaretti 9, 20133, Milan, Italy.ORCID 0009-0002-7797-5378
Gabriele ImperatoDepartment of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Via Giuseppe Balzaretti 9, 20133, Milan, Italy.ORCID 0009-0000-1233-2027
Giulia De CesareDepartment of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Via Giuseppe Balzaretti 9, 20133, Milan, Italy.
Clara CambriaDepartment of Medical Biotechnology and Translational Medicine (BIOMETRA), Via F.lli Cervi 93, Segrate, 20054 Milan and via Vanvitelli 32, Milan, Italy.
Marine H LaporteDepartment of Molecular and Cellular Biology, University of Geneva, Geneva, Switzerland.ORCID 0000-0002-7856-6763
Nicola ZamboniInstitute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.ORCID 0000-0003-1271-1021
Flavia AntonucciDepartment of Medical Biotechnology and Translational Medicine (BIOMETRA), Via F.lli Cervi 93, Segrate, 20054 Milan and via Vanvitelli 32, Milan, Italy.ORCID 0000-0002-0198-4529
Monica Di LucaDepartment of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Via Giuseppe Balzaretti 9, 20133, Milan, Italy.
Nico Mitro *Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Via Giuseppe Balzaretti 9, 20133, Milan, Italy. nico.mitro@unimi.it.ORCID 0000-0002-5000-3619
Elena Marcello *Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Via Giuseppe Balzaretti 9, 20133, Milan, Italy. elena.marcello@unimi.it.ORCID 0000-0003-0452-762X
Ospedale San Giuseppe · ITETH Zurich · CHIstituto Nazionale di Fisica Nucleare, Laboratori Acceleratori e Superconduttività Applicata · ITNeuroscience Institute · ITUniversity of Geneva · CH

Funding

EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions (MSCA) 101072759Fondazione Cariplo (Cariplo Foundation) 2018-0511Fondazione Regionale per la Ricerca Biomedica (FRRB) CP 20/2018Fondazione Umberto Veronesi (Umberto Veronesi Foundation) N/AMinistero della Salute (Italy Ministry of Health) Ricerca Corrente and "5xmille"Ministero dell'Università e della Ricerca (MUR) 2017 (5C22WM)Ministero dell'Università e della Ricerca (MUR) 2017B9NCSXMinistero dell'Università e della Ricerca (MUR) 2017MYJ5THMinistero dell'Università e della Ricerca (MUR) 20202THZAWMinistero dell'Università e della Ricerca (MUR) 202039WMFP
6 · The paper itself

Abstract

Neuronal maturation is the phase during which neurons acquire their final characteristics in terms of morphology, electrical activity, and metabolism. However, little is known about the metabolic pathways governing neuronal maturation. Here, we investigate the contribution of the main metabolic pathways, namely glucose, glutamine, and fatty acid oxidation, during the maturation of primary rat hippocampal neurons. Blunting glucose oxidation through the genetic and chemical inhibition of the mitochondrial pyruvate transporter reveals that this protein is critical for the production of glutamate, which is required for neuronal arborization, proper dendritic elongation, and spine formation. Glutamate supplementation in the early phase of differentiation restores morphological defects and synaptic function in mitochondrial pyruvate transporter-inhibited cells. Furthermore, the selective activation of metabotropic glutamate receptors restores the impairment of neuronal differentiation due to the reduced generation of glucose-derived glutamate and rescues synaptic local translation. Fatty acid oxidation does not impact neuronal maturation. Whereas glutamine metabolism is important for mitochondria, it is not for endogenous glutamate production. Our results provide insights into the role of glucose-derived glutamate as a key player in neuronal terminal differentiation.

Indexed as

GlutamineMonocarboxylic Acid TransportersAnimalsFatty AcidsGlucoseGlutamic AcidNeuronsRatsFatty AcidsGlucoseGlutamic AcidGlutamineMonocarboxylic Acid TransportersGlutamateLocal Protein Translation in NeuronsMetabolismMitochondrial Pyruvate Carrier

Identifiers

PMID38243137
PMCPMC10933318
OpenAlexW4391022768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.